Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study

World Journal of Gastroenterology

Volumn 13, Issue 47, 2007, Pages 6356-6364

  Jung, Ernst Michael ^a,f   Clevert, D A ^b   Schreyer, A G ^a   Schmitt, S ^c   Rennert, J ^a   Kubale, R ^d   Feuerbach, S ^a   Jung, F ^e  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Passau Hospital   (Germany)

^d Hospital Pirmasens   (Germany)

^e INSTITUTE OF MATERIALS RESEARCH   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Contrast harmonic imaging; Liver tumors; Malignant tumor; Quantitative contrast enhancement

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE DISPLAY; IMAGE PROCESSING; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE STUDY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TUMOR CLASSIFICATION; TUMOR VASCULARIZATION;

EID: 37649001202     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i47.6356     Document Type: Article

References (31)

1. Hohmann J, Albrecht T, Oldenburg A, Skrok J, Wolf KJ. Liver metastases in cancer: detection with contrast-enhanced ultrasonography. Abdom Imaging 2004; 29: 669-681
2. Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, Claudon M, Calliada F, Correas JM, LaFortune M, Campani R, Hoffmann CW, Cosgrove DO, LeFevre F. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361-370
3. Bartolozzi C, Donati F, Cioni D, Procacci C, Morana G, Chiesa A, Grazioli L, Cittadini G, Cittadini G, Giovagnoni A, Gandini G, Maass J, Lencioni R. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 2004; 14: 14-20
4. Boozari B, Lotz J, Galanski M, Gebel M. Diagnostic imaging of liver tumours: Current status. Internist (Berl) 2007; 48: 8-20
5. Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A, Vossas U, Hauenstein K, Koch W, Blank W, Oudkerk M, Hahn D, Greis C. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705
6. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
7. Bleuzen A, Huang C, Olar M, Tchuenbou J, Tranquart F. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall Med 2006; 27: 40-48
8. von Herbay A, Haeussinger D, Gregor M, Vogt C. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A) - comparison of SonoVue and Levovist in HCC. Ultraschall Med 2007; 28: 168-175
9. Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 2007; 33: 1515-1526
10. Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B, Wolf KJ, Albrecht T. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 2005; 26: 277-284
11. D'Onofrio M, Rozzanigo U, Masinielli BM, Caffarri S, Zogno A, Malago R, Procacci C. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography. J Clin Ultrasound 2005; 33: 164-172
12. Ogawa S, Kumada T, Toyoda H, Ichikawa H, Kawachi T, Otobe K, Hibi T, Takeshima K, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen. Eur J Radiol 2006; 59: 74-81
13. Wu W, Chen MH, Yin SS, Yan K, Fan ZH, Yang W, Dai Y, Huo L, Li JY. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. AJR Am J Roentgenol 2006; 187: 752-761
14. Krix M, Plathow C, Essig M, Herfarth K, Debus J, Kauczor HU, Delorme S. Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound - initial results. Eur Radiol 2005; 15: 677-684
15. Regge D, Campanella D, Anselmetti GC, Cirillo S, Gallo TM, Muratore A, Capussotti L, Galatola G, Floriani I, Aglietta M. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 2006; 61: 338-347
16. Mamdani B. The Helsinki Declaration, 2000, and ethics of human research in developing countries. Indian J Med Ethics 2004; 1: 94-95
17. Touitou Y, Smolensky MH, Portaluppi F. Ethics, standards, and procedures of animal and human chronobiology research. Chronobiol Int 2006; 23: 1083-1096
18. Linnert K. A Review on the methodology for assessing diagnostic tests. Clin Chem 1988; 34: 1379-1386
19. Delorme S, Krix M, Albrecht T. Ultrasound contrast media - principles and clinical applications. Rofo 2006; 178: 155-164
20. Krix M, Plathow C, Kiessling F, Herth F, Karcher A, Essig M, Schmitteckert H, Kauczor HU, Delorme S. Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. Ultrasound Med Biol 2004; 30: 1355-1363
21. Quaia E. Mikrobubble ultrasound contrast agents: an update. Eur Radiol 2007; 17: 1995-2008
22. Quaia E, Bartolotta TV, Midiri M, Cernic S, Belgrano M, Cova M. Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on baseline scan. Abdom Imaging 2006; 31: 59-64
23. Kim SH, Lee JM, Lee JY, Han JK, An SK, Han CJ, Lee KH, Hwang SS, Choi BI. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR Am J Roentgenol 2005; 184: 1077-1084
24. Quaia E, Palumbo A, Rossi S, Degobbis F, Cernic S, Tona G, Cova M. Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection. AJR Am J Roentgenol 2006; 186: 1560-1570
25. Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol 2006; 186: 1551-1559
26. Vilana R, Bianchi L, Varela M, Nicolau C, Sanchez M, Ayuso C, Garcia M, Sala M, Llovet JM, Bruix J, Bru C. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 2006; 16: 2454-2462
27. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-1609
28. Bryant TH, Blomley MJ, Albrecht T, Sidhu PS, Leen EL, Basilico R, Pilcher JM, Bushby LH, Hoffmann CW, Harvey CJ, Lynch M, MacQuarrie J, Paul D, Cosgrove DO. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 2004; 232: 799-809
29. Delorme S, Krix M, Albrecht T. Ultrasound contrast media - principles and clinical applications. Rofo 2006; 178: 155-164
30. Jung EM, Kubale R, Jungius KP, Jung W, Lenhart M, Clevert DA. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison). Clin Hemorheol Microcirc 2006; 34: 483-497
31. Jung EM, Kubale R, Jungius KP. Vascularization and perfusion of hepatocellular carcinoma: assessment with contrast-enhanced ultrasound using perflutren protein-type A microspheres. Clin Hemorheol Microcirc 2005; 33: 63-73